Lee WC, et al. - This study is performed to examine viral activity and outcome of hepatitis B surface antigen (HBs Ag)-positive deceased grafts transplanted to HBsAg-positive recipients. Findings reveal that under treatment of combined anti-viral nucleoside and nucleotide analogues, HBsAg-positive deceased liver grafts function well with minimal viral activity. To rescue dying patients, use of HBsAg-positive deceased grafts is feasible and increases the donor pool.